Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124177423 | 12417742 | 3 | F | 201303 | 20160822 | 20160530 | 20160831 | EXP | JP-ASTRAZENECA-2016SE56990 | ASTRAZENECA | 847.00 | MON | F | Y | 69.00000 | KG | 20160831 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124177423 | 12417742 | 1 | PS | BYETTA | EXENATIDE | 1 | Subcutaneous | 5UG, TWICE DAILY | Y | 21773 | SOLUTION FOR INJECTION IN PRE-FILLED PEN | ||||||||
| 124177423 | 12417742 | 2 | SS | BYETTA | EXENATIDE | 1 | Subcutaneous | 10 UG, TWICE DAILY | Y | 21773 | SOLUTION FOR INJECTION IN PRE-FILLED PEN | ||||||||
| 124177423 | 12417742 | 3 | SS | BYETTA | EXENATIDE | 1 | Subcutaneous | 5 UG, TWICE DAILY | Y | 21773 | SOLUTION FOR INJECTION IN PRE-FILLED PEN | ||||||||
| 124177423 | 12417742 | 4 | SS | VICTOZA | LIRAGLUTIDE | 1 | 955.8 | MG | 0 | .9 | MG | INJECTION | QD | ||||||
| 124177423 | 12417742 | 5 | SS | VICTOZA | LIRAGLUTIDE | 1 | 955.8 | MG | 0 | .9 | MG | INJECTION | QD | ||||||
| 124177423 | 12417742 | 6 | C | METGLUCO | METFORMIN HYDROCHLORIDE | 1 | Oral | 0 | 250 | MG | TABLET | TID | |||||||
| 124177423 | 12417742 | 7 | C | BASEN | VOGLIBOSE | 1 | Oral | 0 | .3 | MG | TABLET | TID | |||||||
| 124177423 | 12417742 | 8 | C | CADUET NO.4 | 2 | Oral | 0 | 1 | DF | TABLET | QD | ||||||||
| 124177423 | 12417742 | 9 | C | OLMETEC | OLMESARTAN MEDOXOMIL | 1 | Oral | 0 | 40 | MG | TABLET | QD | |||||||
| 124177423 | 12417742 | 10 | C | AMARYL | GLIMEPIRIDE | 1 | Oral | 0 | 1 | MG | TABLET | QD | |||||||
| 124177423 | 12417742 | 11 | C | GLIMICRON | GLICLAZIDE | 1 | 0 | 40 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124177423 | 12417742 | 1 | Type 2 diabetes mellitus |
| 124177423 | 12417742 | 2 | Type 2 diabetes mellitus |
| 124177423 | 12417742 | 3 | Type 2 diabetes mellitus |
| 124177423 | 12417742 | 4 | Type 2 diabetes mellitus |
| 124177423 | 12417742 | 5 | Type 2 diabetes mellitus |
| 124177423 | 12417742 | 6 | Type 2 diabetes mellitus |
| 124177423 | 12417742 | 7 | Type 2 diabetes mellitus |
| 124177423 | 12417742 | 8 | Hypertension |
| 124177423 | 12417742 | 9 | Hypertension |
| 124177423 | 12417742 | 10 | Type 2 diabetes mellitus |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124177423 | 12417742 | HO |
| 124177423 | 12417742 | LT |
| 124177423 | 12417742 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124177423 | 12417742 | Glycosylated haemoglobin increased | |
| 124177423 | 12417742 | Haemangioma | |
| 124177423 | 12417742 | Hypercalcaemia | |
| 124177423 | 12417742 | Metastases to liver | |
| 124177423 | 12417742 | Nausea | |
| 124177423 | 12417742 | Pancreatic carcinoma metastatic | |
| 124177423 | 12417742 | Ventricular tachycardia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124177423 | 12417742 | 1 | 20120604 | 20120923 | 0 | |
| 124177423 | 12417742 | 2 | 20120924 | 20130303 | 0 | |
| 124177423 | 12417742 | 3 | 20130304 | 20140209 | 0 | |
| 124177423 | 12417742 | 4 | 20110221 | 20120603 | 0 | |
| 124177423 | 12417742 | 5 | 20140210 | 0 | ||
| 124177423 | 12417742 | 11 | 2005 | 0 |